These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 1274963)

  • 1. Tardive dyskinesia.
    Clyne KE; Juhl R
    Am J Hosp Pharm; 1976 May; 33(5):481-6. PubMed ID: 1274963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug therapy of tardive dyskinesia.
    Kobayashi RM
    N Engl J Med; 1977 Feb; 296(5):257-60. PubMed ID: 12469
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of tardive dyskinesia caused by neuroleptics].
    Piccinin GL; Piccirilli M; Rizzo PA
    Riv Neurol; 1984; 54(3):199-215. PubMed ID: 6147888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification and treatment of tardive syndromes.
    Fernandez HH; Friedman JH
    Neurologist; 2003 Jan; 9(1):16-27. PubMed ID: 12801428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment of tardive dyskinesia with presynaptically acting dopamine-depleting agents.
    Fahn S
    Adv Neurol; 1983; 37():267-76. PubMed ID: 6858776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug therapies for tardive dyskinesia: Part 1.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2011 Jun; 49(6):13-6. PubMed ID: 21598866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of tardive dyskinesia.
    Widroe HJ; Heisler S
    Dis Nerv Syst; 1976 Mar; 37(3):162-4. PubMed ID: 3393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing tardive dyskinesia.
    Casey DE
    J Clin Psychiatry; 1978 Oct; 39(10):748-53. PubMed ID: 30759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetrabenazine in the treatment of hyperkinetic movement disorders.
    Kenney C; Jankovic J
    Expert Rev Neurother; 2006 Jan; 6(1):7-17. PubMed ID: 16466307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tardive dyskinesia: clinical, biological, and pharmacological perspectives.
    Berger PA; Rexroth K
    Schizophr Bull; 1980; 6(1):102-16. PubMed ID: 6102788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tardive dyskinesia.
    Goetz CG; Klawans HL
    Neurol Clin; 1984 Aug; 2(3):605-14. PubMed ID: 6152483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history and treatment of tardive dystonia.
    Kang UJ; Burke RE; Fahn S
    Mov Disord; 1986; 1(3):193-208. PubMed ID: 2904118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug treatment of diseases characterized by abnormal movements.
    Marsden CD
    Proc R Soc Med; 1973 Sep; 66(9):871-3. PubMed ID: 4281483
    [No Abstract]   [Full Text] [Related]  

  • 14. Tardive dystonia.
    Kang UJ; Burke RE; Fahn S
    Adv Neurol; 1988; 50():415-29. PubMed ID: 3400500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A therapeutic approach to tardive dyskinesia.
    Fahn S
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):19-24. PubMed ID: 2858474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential striatal levels of TNF-alpha, NFkappaB p65 subunit and dopamine with chronic typical and atypical neuroleptic treatment: role in orofacial dyskinesia.
    Bishnoi M; Chopra K; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1473-8. PubMed ID: 18554768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valeriana officinalis does not alter the orofacial dyskinesia induced by haloperidol in rats: role of dopamine transporter.
    Fachinetto R; Villarinho JG; Wagner C; Pereira RP; Avila DS; Burger ME; Calixto JB; Rocha JB; Ferreira J
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1478-86. PubMed ID: 17669571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deanol acetamidobenzoate (Deaner) in tardive dyskinesia.
    Stafford JR; Fann WE
    Dis Nerv Syst; 1977 Dec; 38(12 Pt 2):3-6. PubMed ID: 590063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tardive tremor.
    Stacy M; Jankovic J
    Mov Disord; 1992; 7(1):53-7. PubMed ID: 1348352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of tardive dyskinesia. II. Short-term efficacy of dopamine-blocking agents haloperidol and thiopropazate.
    Kazamatsuri H; Chien C; Cole JO
    Arch Gen Psychiatry; 1972 Jul; 27(1):100-3. PubMed ID: 4555826
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.